Article
Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2017
Yu Lijian, Kim Haesook T, Kasar Siddha, Benien Parul, Du Wei, Hoang Kevin, Aw Andrew, Tesar Bethany, Improgo Reina, Fernandes Stacey, Radhakrishnan Saranya, Klitgaard Josephine, Lee Charles, Getz Gad, Setlur Sunita R, Brown Jennifer R
Abstract excerpt
PURPOSE: Chronic lymphocytic leukemia (CLL) with 17p deletion typically progresses quickly and is refractory to most conventional therapies. However, some del(17p) patients do not progress for years, suggesting that del(17p) is not the only driving event in CLL progression. We hypothesize that other concomitant genetic abnormalities underlie the clinical heterogeneity of del(17p) CLL. EXPERIMENTAL DESIGN: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
